Featured Research

from universities, journals, and other organizations

Hitting Where It Hurts: Exploiting Cancer Cell 'Addiction' May Lead To New Therapies

Date:
June 5, 2009
Source:
Cell Press
Summary:
A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The research identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.

A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The research, published by Cell Press in the June 2nd issue of the journal Cancer Cell, identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.

Although previous work has identified K-Ras as a frequently mutated oncogene in solid tumors, development of clinically effective cancer therapies that target K-Ras has proven challenging and has been largely unsuccessful. "There remains a pressing need to identify pharmacologically tractable components of K-Ras-driven tumorigenesis," says senior study author Dr. Jeff Settleman from Massachusetts General Hospital Cancer Center and Harvard Medical School.

Dr. Settleman and colleagues undertook a series of studies to identify characteristics that define "K-Ras addiction". Oncogene addiction refers to the requirement of a tumor for the sustained expression of a single aberrantly activated gene, even in the presence of other mutations. Settleman's group identified two classes of cancer cells: K-Ras mutant dependent and K-Ras-independent. "We established a gene expression signature that distinguishes these two groups and identified genes that are specifically upregulated in K-Ras-dependent cells and required for their viability," says Dr. Settleman.

The researchers went on to show that several of the genes associated with K-Ras-dependent cancer cells were required to maintain a state of cell differentiation. Furthermore, oncogene dependency (and therefore cancer cell viability) was strongly linked with the differentiation state. "The notion that poorly differentiated tumors are generally more drug resistant and are associated with poorer prognosis has been widely recognized in clinical oncology, and our findings might provide some mechanistic insight into this observation," offers Dr. Settleman.

The authors conclude that comparing gene expression profiles between cancer cell lines on the basis of oncogene addiction is likely to provide a broadly useful strategy for context-specific drug target discovery. In this study, one particular gene, ITGB6, was strongly associated with differentiated K-Ras driven tumors. "Efforts to target the activity of ITGB6 are currently underway," says Dr. Settleman.

The researchers include Anurag Singh, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Patricia Greninger, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Daniel Rhodes, University of Michigan Medical School, Ann Arbor, MI; Louise Koopman, Biogen Idec, Cambridge, MA; Sheila Violette, Stromedix Inc., Cambridge, MA; Nabeel Bardeesy, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; and Jeff Settleman, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "Hitting Where It Hurts: Exploiting Cancer Cell 'Addiction' May Lead To New Therapies." ScienceDaily. ScienceDaily, 5 June 2009. <www.sciencedaily.com/releases/2009/06/090601121657.htm>.
Cell Press. (2009, June 5). Hitting Where It Hurts: Exploiting Cancer Cell 'Addiction' May Lead To New Therapies. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2009/06/090601121657.htm
Cell Press. "Hitting Where It Hurts: Exploiting Cancer Cell 'Addiction' May Lead To New Therapies." ScienceDaily. www.sciencedaily.com/releases/2009/06/090601121657.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins